.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03C_Estrogens.G03CC07_ConjugatedEstrogensAndBazedoxife.ConjugatedEstrogensAndBazedoxife .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03C_Estrogens.G03CC07_ConjugatedEstrogensAndBazedoxife.ConjugatedEstrogensAndBazedoxife| name: | ConjugatedEstrogensAndBazedoxifene |
| ATC code: | G03CC07 | route: | oral |
| n-compartments | 1 |
Conjugated estrogens and bazedoxifene is a combination medication used primarily for the treatment of moderate to severe vasomotor symptoms associated with menopause and for the prevention of postmenopausal osteoporosis in women with a uterus. The conjugated estrogens provide estrogen receptor stimulation while bazedoxifene acts as a selective estrogen receptor modulator (SERM) to reduce endometrial hyperplasia risk. The combination is approved for use in several countries, including the United States.
Estimated pharmacokinetic parameters for healthy postmenopausal women after oral administration.